By 2025, tezepelumab became the most frequently initiated biologic, accounting for 33% of new starts in the cohort.

Objective Children and young people (CYP) with special educational needs (SENs) have an increased risk of psychopathology and ...

Despite affecting thousands of Ugandans, asthma remains widely misunderstood. Dr Kanishka Salunkhe, a pulmonologist, breaks down the common myths that delay diagnosis, fuel fear, and prevent proper ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Glaxo Smith Kline’s decision to discontinue a popular children’s asthma inhaler, Flovent, more than two years ago has caused disruptions for physicians and health consequences for families nationwide, ...

With more than 15 years of experience crafting content about all aspects of personal finance, Michael Benninger knows how to identify smart moves for your money. His work has been published by Intuit, ...

Artificial untelligence (AI) stocks under $10 are publicly traded companies developing or applying AI technologies, with stock prices below $10 per share. These lower-priced AI stocks can present ...

While AI and gold were all the rage in 2025, lately investors have been looking for stocks with long-term power instead of short-term appeal. The best growth stocks are built on durable trends that ...

Ashlie Rodriguez is FOX 10's weekend evening anchor and weekday reporter. She is an award-winning veteran journalist with 15 years' experience in both print and television news. She began her career ...